305 related articles for article (PubMed ID: 16194658)
21. Physicians and industry: regaining independence.
Hundley RF
J Ark Med Soc; 2006 Dec; 103(6):124-5. PubMed ID: 17190407
[No Abstract] [Full Text] [Related]
22. Doctors and the drug industry: how can we handle potential conflicts of interest?
Alpert JS
Am J Med; 2005 Feb; 118(2):99-100. PubMed ID: 15694888
[No Abstract] [Full Text] [Related]
23. Financial disclosures in clinical practice guidelines.
Kahn JM; Rubenfeld GD
Crit Care Med; 2010 Aug; 38(8):1755-6; discussion 1756-7. PubMed ID: 20647810
[No Abstract] [Full Text] [Related]
24. Doctors and the drug industry: reader feedback.
Adams CD
Am J Med; 2005 Oct; 118(10):1177; author reply 1178. PubMed ID: 16194660
[No Abstract] [Full Text] [Related]
25. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
[TBL] [Abstract][Full Text] [Related]
26. Most Australians believe that drug company payments influence doctors' decisions.
Moynihan R
BMJ; 2012 Feb; 344():e1076. PubMed ID: 22331321
[No Abstract] [Full Text] [Related]
27. Physicians, the industry and population health.
Gérvas J; Mansfield PR
J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
[No Abstract] [Full Text] [Related]
28. High-tech stealth being used to sway doctor prescriptions.
Stolberg SG; Gerth J
N Y Times Web; 2000 Nov; ():A1, A22. PubMed ID: 12159839
[No Abstract] [Full Text] [Related]
29. The medical profession and the pharmaceutical industry: when will we open our eyes?
Breen KJ
Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
[TBL] [Abstract][Full Text] [Related]
30. Getting drug money out of doctors' offices...
Nagarkar PA
Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(1):13-7. PubMed ID: 20178201
[No Abstract] [Full Text] [Related]
31. Exploring the link between industry payments to doctors and prescribing habits.
Carlat D
BMJ; 2014 Nov; 349():g6651. PubMed ID: 25378357
[No Abstract] [Full Text] [Related]
32. Re "Getting drug money out of doctors' offices".
Jacobs J
Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):50; author reply 50-1. PubMed ID: 20690557
[No Abstract] [Full Text] [Related]
33. The physician payment sunshine act is here--are you ready?
Lazarus JA
J Miss State Med Assoc; 2013 Jun; 54(6):177. PubMed ID: 23991517
[No Abstract] [Full Text] [Related]
34. [Clinical practice and pharmaceutical industry: an always difficult relationship].
Mastai R
Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
[No Abstract] [Full Text] [Related]
35. [Strategies for drug promotion].
Polonuer JL
Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
[No Abstract] [Full Text] [Related]
36. Doctors and drug companies--scrutinizing influential relationships.
Campbell EG
N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
[No Abstract] [Full Text] [Related]
37. Ethical obligations under New Jersey's mandated pharmaceutical disclosures.
Schoppmann MJ
MD Advis; 2012; 5(4):26-8. PubMed ID: 23132105
[No Abstract] [Full Text] [Related]
38. Managing conflicts of interest and commitment: academic medicine and the physician's progress.
Kachuck NJ
J Med Ethics; 2011 Jan; 37(1):2-5. PubMed ID: 21149321
[No Abstract] [Full Text] [Related]
39. The physician as hospital employee.
Mehta S; Asch DA; Peck CA
Virtual Mentor; 2013 Feb; 15(2):107-13. PubMed ID: 23398794
[No Abstract] [Full Text] [Related]
40. Radiology and industry: can this relationship be saved?
Forman HP
J Am Coll Radiol; 2006 May; 3(5):333-4. PubMed ID: 17412076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
